Vaccine Manufacture and Supply – News and Features

The company have announced plans for a new facility specializing in plant-based vaccines and therapeutics which will more than double their current work force in the city.

First-of-its-kind West Nile virus vaccine developed by OHSU is now in Phase I clinical trials.

The vaccine was developed by the Chemo-Sero Therapeutic Research Institute (Kaketsuken) in collaboration with GlaxoSmithKline using Valneva’s EB66® cell line.

Agreement on EB66® cell line for human and veterinary vaccines in People’s Republic of China.

The ability to grow influenza in cell culture rather than chicken eggs paves the way for mass production of the vaccine.

Acquisition enhances Texas’ growing reputation as a global biotechnology leader.

Commitment to speed Ebola vaccine development and significantly expand production.

Company has committed up to $200M to vaccine program in development at its Janssen Pharmaceutical Companies.

University of Pennsylvania and Children's Hospital of Philadelphia studies reveal unprecedented results with investigational therapy made from patients' own immune cells.

“Transforming the Vaccine Manufacturing Chain,” highlights how pharmaceutical companies can ensure quality and accelerate time to market with Manufacturing Intelligence technology.